Computed Tomography Texture Analysis for Predicting Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors

BACKGROUND: The treatment responses of immune checkpoint inhibitors in metastatic renal cell carcinoma (mRCC) vary, requiring reliable prognostic biomarkers. We assessed the prognostic ability of computed tomography (CT) texture analysis in patients with mRCC treated with programmed death receptor-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyo Jung, Qin, Lei, Bakouny, Ziad, Krajewski, Katherine M, Van Allen, Eliezer M, Choueiri, Toni K, Shinagare, Atul B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074990/
https://www.ncbi.nlm.nih.gov/pubmed/35348767
http://dx.doi.org/10.1093/oncolo/oyac034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074990/
https://www.ncbi.nlm.nih.gov/pubmed/35348767
http://dx.doi.org/10.1093/oncolo/oyac034

Ejemplares similares